IRIS
FASANO, Serena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 593
NA - Nord America 444
AS - Asia 110
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.153
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 442
IE - Irlanda 313
IT - Italia 72
GB - Regno Unito 69
CN - Cina 48
SG - Singapore 40
DE - Germania 28
FR - Francia 26
GR - Grecia 26
SE - Svezia 25
UA - Ucraina 22
TR - Turchia 11
IN - India 6
FI - Finlandia 5
JP - Giappone 3
BE - Belgio 2
BR - Brasile 2
CL - Cile 2
PL - Polonia 2
CA - Canada 1
CO - Colombia 1
CZ - Repubblica Ceca 1
EU - Europa 1
GL - Groenlandia 1
HK - Hong Kong 1
MY - Malesia 1
PT - Portogallo 1
RU - Federazione Russa 1
Totale 1.153
Salva come PNG Salva come JPEG
Città #
Dublin 313
Chandler 96
Jacksonville 69
Princeton 33
Roxbury 32
Medford 24
Singapore 21
Bremen 20
Caserta 15
Cambridge 11
Des Moines 11
Nanjing 8
Wilmington 8
Beijing 7
Boardman 7
Jinan 7
Ann Arbor 6
Marseille 5
Napoli 4
New York 4
Sant'Angelo in Formis 4
Villa Literno 4
Hyderabad 3
Shenyang 3
Ashburn 2
Brussels 2
Campo Grande 2
Changsha 2
Hebei 2
Jiaxing 2
Kraków 2
Lanzhou 2
Lappeenranta 2
Mcallen 2
Milan 2
Minerbio 2
Mountain View 2
Nanchang 2
Redwood City 2
San Mateo 2
Santiago 2
Taiyuan 2
Taizhou 2
Tianjin 2
Villaricca 2
Zhengzhou 2
Brno 1
Cagliari 1
Davis 1
Edinburgh 1
Ferrara 1
Genova 1
Guangzhou 1
Gunzenhausen 1
Haikou 1
Hongtong 1
Kiev 1
Kunming 1
Marano Di Napoli 1
Massamá 1
Medellín 1
Mumbai 1
Munich 1
Nuuk 1
Ottawa 1
Petaling Jaya 1
Woodbridge 1
Xiangfen 1
Totale 781
Salva come PNG Salva come JPEG
Nome #
Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus 54
Prevalence and factors associated with glucocorticoids (GC) use in systemic sclerosis (SSc): a systematic review and meta-analysis of cohort studies and registries 53
The incidence of cardiovascular events in Italian patients with systemic lupus erythematosus is lower than in North European and American cohorts: Implication of disease-associated and traditional risk factors as emerged by a 16-year retrospective GIRRCS study 51
Cardiac involvement in undifferentiated connective tissue disease at risk for systemic sclerosis (otherwise referred to as very early-early systemic sclerosis): a TDI study 50
Low-dose aspirin as primary prophylaxis for cardiovascular events in systemic lupus erythematosus: A long-term retrospective cohort study 49
Mortality in Italian patients with rheumatoid arthritis: Evidence for a low mortality rate from cancer and infections in patients followed up at a tertiary center 41
Rituximab in the treatment of inflammatory myopathies: a review 38
Lung involvement in stable undifferentiated connective tissue diseases: a rheumatology perspective 38
Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: Putative implication of a low anti-carbamylated protein antibodies prevalence 38
Low-dose aspirin as primary prophylaxis for cardiovascular events in rheumatoid arthritis: an Italian multicentre retrospective study 37
Current pharmacological treatment of idiopathic inflammatory myopathies 37
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 37
Clinical features of patients with systemic lupus erythematosus according to health-related quality of life, entity of pain, fatigue and depression: a cluster analysis 36
Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review 35
Undifferentiated connective tissue disease at risk of systemic sclerosis: A weighted score to identify patients who will evolve 35
Biomarker panels may be superior over single molecules in prediction of renal flares in systemic lupus erythematosus: an exploratory study 35
Health status and concomitant prescription of immunosuppressants are risk factors for hydroxychloroquine non-adherence in systemic lupus patients with prolonged inactive disease. 34
Incidence of COVID-19 in an Italian cohort of patients with systemic lupus erythematosus: an observational survey 33
ILC3 in Axial Spondyloarthritis: the Gut Angle 30
Biologic treatments for idiopathic inflammatory myopathies 30
Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual 26
Early disease and low baseline damage predict response to belimumab in patients with systemic lupus erythematosus 25
Subclinical Pancreatitis as Onset of Systemic Lupus Erythematosus: Case Report and Review of the Literature 24
The association between duration of remission, fatigue, depression and health-related quality of life in Italian patients with systemic lupus erythematosus 23
Pathogenesis of primary Sjögren's syndrome beyond B lymphocytes 23
Influence of hydroxychloroquine blood levels on adhesion molecules associated with endothelial dysfunction in patients with systemic lupus erythematosus 22
Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: Results of the DeSScipher inception cohort study 22
Thrombocytopenia in the Antiphospholipid Syndrome 22
Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 21
Present and novel biologic drugs in primary Sjogren's syndrome 20
Autoimmune gastrointestinal complications in patients with systemic lupus erythematosus: case series and literature review 19
Precision medicine in systemic lupus erythematosus 19
"What is fuelling the immune response in systemic lupus erythematosus?" Evaluating the key metabolites driving plasmablast differentiation 18
Bruton's Tyrosine Kinase Inhibitors: A New Therapeutic Target for the Treatment of SLE? 18
Systematic review and meta-analysis of cardiovascular risk in rheumatological disease: Symptomatic and non-symptomatic events in rheumatoid arthritis and systemic lupus erythematosus 17
Microbiome Changes in Connective Tissue Diseases and Vasculitis: Focus on Metabolism and Inflammation 16
The role of aspirin in the primary prevention of accelerated atherosclerosis in systemic autoimmune rheumatic diseases 14
Which patients with systemic lupus erythematosus in remission can withdraw low dose steroids? Results from a single inception cohort study 13
Risk factors of flare in patients with systemic lupus erythematosus after glucocorticoids withdrawal. A systematic review and meta-analysis 12
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study—Joint and Skin (BeRLiSS-JS) 10
Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus 9
Systemic lupus erythematosus and the role of the GP 9
Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview 8
Recognition and management of systemic lupus erythematosus 8
Totale 1.209
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.493
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.493
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020113 15 8 13 3 11 2 25 19 6 4 6 1
2020/2021132 2 0 5 7 37 8 24 2 8 3 35 1
2021/2022193 5 0 0 3 82 0 9 4 10 3 12 65
2022/2023485 39 3 20 14 50 29 0 23 281 1 13 12
2023/2024191 16 17 13 15 80 6 0 1 1 1 5 36
Totale 1.209